Guidelines suggest renoprotective drugs, such as angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs), should be prescribed to decrease elevated blood pressure in type 2 diabetes mellitus patients at high risk of kidney decline, as these drugs are beneficial in preventing further kidney impairment [8–11]. This evidence concerns the gene ACE and blood pressure trait.